The test examines the activity of 21 genes in a breast cancer tumor sample. These genes are involved in various biological pathways, such as cell proliferation, invasion, and hormone receptor signaling. The results are combined to produce a Recurrence Score ranging from 0 to 100. A lower score suggests a lower risk of recurrence, while a higher score indicates a higher risk.